# HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598

> **NCT00896909** · — · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 44 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **GENETIC:** gene expression analysis
- **GENETIC:** mutation analysis
- **GENETIC:** polymerase chain reaction
- **OTHER:** diagnostic laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00896909
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02-02
- **Primary completion:** 2006-07-02
- **Final completion:** 2006-07-02
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00896909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00896909, "HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00896909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*